Clinical Trial Update: ALA and Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial involving 5-aminolevulinic acid (ALA) for prostate cancer is noted; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Prostate Cancer

Drugs mentioned

• 5-aminolevulinic acid (ALA) (5-aminolevulinic acid)

Snippet

Sponsor: University of Toronto | Conditions: Atrial Fibrillation, Diet Therapy | Phase 2 | Status: UNKNOWN